Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hemlibra
Biotech
Novo Nordisk hemophilia hopeful can't shake Pfizer's shadow
Novo Nordisk has insisted concizumab will make a “good offering” for patients as mixed phase 3 data suggest Pfizer’s candidate could have an edge.
James Waldron
Jun 27, 2023 4:00pm
Novo's attempt to snatch Roche's hemophilia crown gets serious
Jul 12, 2022 9:21am
Sanofi preps hemophilia duo for patients seeking normalcy
Jul 10, 2022 9:45am
Sanofi hits goal in hemophilia A and plots race to regulators
Mar 9, 2022 7:15am